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The aim of this study was to analyse the correlates of reduced bone mineral density in patients with chronic
obstructive pulmonary disease (COPD), with special regard to a possible protective role of hypercapnia.
One hundred and four consecutive COPD inpatients in stabilized respiratory conditions underwent a
comprehensive assessment of their health status. Bone mineral density was measured by X-ray absorptiometry
at the lumbar site and at the femoral neck site. Differences in health-related variables between patients with (group
O, n¼62) and without (group N, n¼42) lumbar and/or femoral neck osteoporosis were assessed first by univariate
analysis and then by logistic regression analysis aimed to identify independent correlates of osteoporosis.
Group O was characterized by worse nutritional status, as reflected by indices exploring either lean or fat mass,
and by a trend towards lower forced expiratory volume in 1 sec/forced vital capacity ratio. Arterial tension of
carbon dioxide lacked any correlation with bone mineral density. According to the logistic regression analysis, body
mass index  22 kgm72 qualified as the only and positive independent correlate of osteoporosis (odds ratio¼4?18;
95% confidence intervals¼1?19–14?71).
In conclusion, malnutrition characterizes COPD patients with osteoporosis, while mild to moderate hypercapnia
lacks either a positive or negative effect on bone mineral density. Longitudinal studies are needed to identify
predictors rather than correlates of bone mineral density.
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A well-defined association between chronic obstructive
pulmonary disease (COPD) and osteoporosis has been
reported (1,2). In these patients, inactivity, lower sunlight
exposure, smoking, use of corticosteroids, nutritional
impairment and hypercatabolic effects of recurrent inflam-
matory exacerbations probably contribute to accelerate the
decline of bone mineral density (BMD) (3). Among
nutritional parameters both body weight and body mass
index (BMI) were reported to be inversely correlated with
BMD (4,5). Interestingly, chronically inhaled and oral
corticosteroids were found to have comparable negative
effects on BMD (5). In advanced COPD, acidosis might
favour progressive bone loss because bone hydroxyapatite
buffers hydrogen ions (6). On the other hand, metabolic
rather than respiratory acidosis has been found to
negatively affect BMD in some experimental models (7).Received 24 November 1999 and accepted in revised form 16 June
2000. Published online 18 September 2000.
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0954-6111/00/111079+06 $35?00/0Indeed, the retention of carbon dioxide (CO2) and, then,
the generation of bicarbonates (HCO37) seems to exert
some protective effect on bone mass (8–13). The few
available clinical studies assessing the relationship between
CO2 retention and BMD provide conflicting results (14,15).
Differences in length of history of COPD and in the
respective prevalence of the above-reported risk factors
might partially account for this disagreement. Furthermore,
lack of or incomplete quantification of health-related
behaviours such as smoking habits and consumption of
alcohol is likely to confound the results.
The present study aims to identify the main correlates of
low BMD and to verify whether, and to what extent, the
acid–base balance correlates with BMD in a COPD
population carefully characterized with regard to variables
affecting BMD.
Methods
SUBJECTS AND DATA COLLECTION
One hundred and four patients consecutively admitted to
the respiratory ward of the University Hospital in a 9-# 2000 HARCOURT PUBLISHERS LTD
1080 R. A. INCALZI ET AL.month period for an exacerbation of COPD were enrolled
in a cross-sectional study. All but 25 of these patients
regularly attended the outpatient respiratory department of
the same hospital. Each patient gave his/her informed
consent to participate in the study. The study protocol
conformed to guidelines by the local Ethical Committee.
COPD was diagnosed according to criteria provided by
the American Thoracic Society (ATS) (16). Patients were
studied after the resolution of acute exacerbation provided
that they were in stable conditions defined as follows:
performance of activities of daily living (ADL) had to be
comparable to that reported to be usual for the individual
patient while at home; for subjects inhaling oxygen enriched
air, an arterial oxygen saturation (SaO2) of at least 90% had
to be maintained with the same inspired fraction of oxygen
used for oxygen therapy at home.
Criteria of exclusion from the study were: premenopausal
status; previous or actual post-menopausal hormone
replacement therapy or any kind of therapy, e.g. dipho-
sphonates, or co-morbid conditions such as chronic renal
failure, known to affect bone turn over; cancer and/or near
terminal illness. Use of steroids and/or diuretics, which
affect bone turn over, did not qualify as exclusion criterion.
The patient underwent a multi-dimensional assessment
exploring the following domains:
(i) Sociodemographic: age, sex, education, occupational
role before retirement defined according to Featherman and
Hauser (17). (ii) Behavioural variables: previous smokers,
i.e. patients who stopped smoking at least 6 months before
were distinguished from actual smokers; the average
number of daily smoked cigarettes was recorded and
pack-years were calculated. The daily consumption of wine
was rated as follows: none, less than 0?5 l, 0?5–1 l41 l. The
composition of the diet was estimated by a food-frequency
questionnaire and the average daily calcium intake was
assessed according to the calcium content of servings (18).
(iii) Physical function was categorized according to the
Barthel scale of disability (19). This scale takes into account
nine indices of self-care and six of mobility. The final score
ranges between 0 and 100 (19). (iv) Cognitive function was
rated by the mini-mental status (MMS) test (20). The final
score ranges between 0 and 30. The cut-off value of 24 has
been reported to distinguish normal from abnormal
performance (20). However, in older and less educated
subjects a cut-off of 21 is frequently used (21). (v) Affective
status was assessed by the short form of the geriatric
depression scale (GDS). This simplified form of the original
scale includes 15 items; a final score greater than seven is
considered to be consistent with a depressive trait (22). (vi)
Co-morbid diseases were diagnosed by the assessing
physician according to the International Classification of
Diseases (23). A standardized index of co-morbidity was
computed according to the method of Charlson et al. (24).
(vii) The number and duration of courses of systemic
steroid therapy and of diuretics during the last year was
approximately estimated by interviewing the patient and
his/her relatives or care-givers and by reviewing drug
prescriptions, when available. For the 79 patients regularly
attending the outpatient respiratory department informa-
tion was primarily gathered from individual sheets. Patientswho were administered systemic steroids and diuretics for
at least 4 and 7 months, respectively, were considered to be
frequent users of such drugs. (viii) Length of history of
COPD was estimated by an account of historical data
provided by the patient and of the available medical
documentation. Given that 79 patients regularly attended
the outpatient respiratory department of the same hospital,
detailed historical information was available for most of the
patients. (ix) Respiratory function: the patient performed a
forced expiratory manoeuvre with a water-sealed compu-
terized Baires system (Biomedin, Padova, Italy) fulfilling
the ATS recommendations for diagnostic spirometry (25).
Inability to meet the ATS criteria for acceptability and
reproducibility was criterion for exclusion from the study.
Arterial blood gases were measured with the patient
breathing room air or oxygen-enriched air through a facial
mask, if needed. The acid–base balance reflecting the usual
condition of the patient on continuous oxygen therapy was
considered to be a more reliable correlate of BMD than
acid–base balance measured without oxygen supplementa-
tion. (x) Anthropometric data: weight and height were
measured according to guidelines by de Groot and van
Staveren and body mass index (BMI) was obtained as
follows: weight (kg)/height (m)2 (26). Mid-arm circumfer-
ence (MAC) and triceps skin-fold (TSF) were measured
with a centimeter and a John Bull skinfold caliper (British
Indicator Ltd), according to Tanner (27). Mid-arm muscle
circumference (MAMC) was obtained as follows:
MAMC¼MAC7(3?1460?16TSF) (28). Serum albumin
and haemoglobin concentrations were measured. (xi) BMD
was assessed at lumbar and femoral neck sites by double
energy X-ray absorptiometry (DXA) using a Hologic Dexa
QDR 2000 (Hologic, Walthman, MA, U.S.A.). In order to
exclude the confounding effect of osteophytes, lateral scan
of the spine was systematically performed (29).
STATISTICAL ANALYSIS
Patients were grouped according to whether they had
(group O) or did not have (group N) a BMD value at the
lumbar column and/or the femoral neck more than 2?5 SD
below the young adult mean value. We remind the reader
that this level of BMD is considered to represent the
threshold for the diagnosis of osteoporosis (30). Differences
between groups were assessed by a w2-test for dichotomous
variables and by a Student’s t-test or Mann–Whitney test
for continuous variables according to whether the variable
did, or did not have, both normal distribution and
homogeneous variance, respectively (31).
Variables significantly or near significantly different
between groups at the univariate analysis were entered in
a logistic regression model having the presence of osteo-
porosis as dependent variable and adjusted for age and
gender. Arterial CO2 tension (PaCO2) was forced into the
model in order to evaluate the effect of hypercapnia on
BMD. The independent variable was considered to be
significantly associated with the outcome if one was not
enclosed between the 95% confidence intervals (95% CI) of
the odds ratio (OR) (32).
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Differences between groups O and N are shown in Tables 1
and 2. Groups were comparable with regard to age, gender,
health-related behaviours, neuropsychological and func-
tional status characteristics. Group N had significantly
better nutritional status, as reflected by average nutritional
indices such as BMI and MAC and, to a lesser extent, by
indices selectively reflecting fat-free (MAMC) and fat mass
(TSF). Haemoglobin and albumin concentrations were not
significantly different between groups. Dynamic lung
volumes and arterial blood gases did not distinguish
groups, but a trend towards higher forced expiratory
volume in 1 sec/forced vital capacity (FEV1/FVC) ratio in
group N was evident. Groups also had comparable
duration of COPD history, prevalence of co-morbid
diseases and frequent user of steroids for any route and
diuretics.
Table 3 summarizes the results of the logistic regression
analysis. BMI22 kgm72, which corresponds to the lowest
quartile of BMI distribution, was identified as the only
independent correlate of the outcome osteoporosis. Pa-
CO246?93 kPa, which selects the highest quartile of PaCO2
distribution, lacked predictability. Both MAC and TSF,
which were significantly lower in the osteoporotic group,
were not entered into the logistic regression analysis inTABLE 1. Differences in sociodemographic, nutritional and ne
independence between patients with (group O) and without (gr
Group O
Number 62
Males 37 (59?7)
Age (years) 71?31+7?55
Years of formal education 7?25+4?19
Actual smokers 35 (56?4)
Pack-years of smoking 51?52+29?27
Daily wine intake
0 18 (37?5)
4 1/2 l 26 (54?2)
41/2 l 4 (8?3)
Daily calcium intake (mg) 886?42+354?14
BMI (kg m72) 24?46+4?11
MAC (mm) 248?00+30?55
MAMC (mm) 210?29+21?03
TSF (mm) 13?03+6?71
Serum albumin (gL71) 41?43+3?97
Hemoglobin (gL71) 134?36+19?31
GDS 6?17+3?31
MMS 26?84+3?26
Barthel index 80?92+19?59
Values are presented as mean+ SD or as absolute number with p
arm circumference; MAMC: mid-arm muscle circumference; TS
mini-mental status.
*By w3-test for dichotomous variables and by unpaired t-te
variables.order to prevent their collinearity with BMI. Indeed, it
seemed logical to test the correlative role of MAMC besides
that of BMI because MAMC was the only available index
of fat-free mass.
Discussion
No relationship between hypercapnia and osteoporosis was
observed. This finding should be interpreted in the light of
the effects that CO2 exerts on the bone matrix and of its role
as a marker of COPD severity. Indeed, increased formation
of carbonated apatite has been observed in the bone
exposed to a medium having high PCO2 (8,13). The
concentration of HCO37 is a direct function of PCO2 and
it is known that HCO37 exerts an important protective
effect on the bone by preventing the release of calcium (10).
Thus, increasing HCO37 concentration at constant pH
results in decreased calcium eux from the bone (10).
Collaterally, chronic respiratory acidosis has been shown to
enhance gut calcium absorption in the rat (13). Further-
more, several studies on cultured mouse calvarie have
shown that the homeostatic role of the bone changes as a
function of the metabolic or respiratory type of acidosis (8–
13): chronic metabolic acidosis promotes a dramatic
calcium eux from the bone of the live calvariae, whereasuropsychologic characteristics and in the level of physical
oup N) osteoporosis
Group N P-value (*)
42
31 (73?8) 0?137
70?24+6?92 0?527
6?34+3?55 0?671
22 (52?3) 0?459
56?24+35.?5 0?548
9 (32?1)
17 (60?7) 0?857
2 (7?1)
731?48+190?08 0?134
28?94+4?61 50?0001
281?52+32?73 50?0001
228?98+28?81 0?0037
17?62+9?17 0?0203
42?77+3?65 0?142
139?55+15.?48 0?174
5?43+3?42 0?315
27?34+2?23 0?559
83?00+20?74 0?641
ercentage in parentheses. BMI: body mass index; MAC: mid-
F: triceps skin-fold; GDS: geriatric depression scale; MMS:
st or Mann–Whitney test, as appropriate, for continuous
TABLE 2. Differences in respiratory characteristics, medical problems, and pharmacological therapy between patients with
(group O) and without (group N) osteoporosis
Group O Group N P-value (*)
FVC (% predicted) 64?35+20?13 63?86+21?97 0?932
FEV1 (% predicted) 40?03+20?19 44?19+21?52 0?647
FEV1/FVC (%) 45?22+15?31 50?66+16?71 0?097
PaO2 (kPa) 8?34+1?67 8?42+1?82 0?807
PaCO2 (kPa) 5?88+1?19 6?22+1?41 0?176
PH 7?42+0?03 7?41+0?04 0?508
PA–aO2 (kPa) 5?19+2?39 5?01+2?74 0?735
FiO2 (%) 21?77+2?28 22?19+2?46 0?620
COPD duration (years) 13?36+10?46 15?03+9?50 0?542
Charlson’s co-morbidity index 2?95+1?72 2?69+1?63 0?553
Congestive heart failure 9 (14?5) 8 (19) 0?539
Diabetes mellitus 9 (14?5) 7 (16?7) 0?765
Frequent users of systemic steroids 28 (45?2) 18 (42?9) 0?816
Frequent users of inhaled steroids 49 (79) 36 (85?7) 0?387
Frequent users of diuretics 24 (38?7) 13 (31) 0?417
Values are presented as mean+SD or as absolute number with percentage in parentheses. FVC, forced vital capacity; FEV1,
forced expiratory volume in 1 sec; PaO2, arterial oxygen tension; PaCO2, arterial carbon dioxide tension; PA–aO2, alveolar–
arterial oxygen difference; FiO2, inspired fraction of oxygen.
*By w2-test for dichotomous variables and by unpaired t-test or Mann–Whitney test, as appropriate, for continuous variables.
TABLE 3. Logistic regression analysis having osteoporosis as outcome
Variables Odds ratio 95% Confidence intervals Coecient Standard error P-value
BMI422 kgm72* 4?18 1?19–14?71 1?43 0?64 0?026
PaCO246?93 kPa
{ 0?60 0?23–1?61 70?50 0?49 0?313
FEV1/FVC534%
* 1?65 0?62–4?37 0?49 0?49 0?318
MAMC5201?34mm* 1?34 0?55–3?26 0?29 0?45 0?512
Age 1?01 0?95–1?08 0?01 0?03 0?679
Male gender 0?54 0?21–1?38 70?61 0?47 0?199
Abbreviations as in Tables 1 and 2.
*Corresponding to the lowest quartile of the distribution of BMI, FEV1/FVC and MAMC.
{Corresponding to the highest quartile of the distribution of PaCO2.
1082 R. A. INCALZI ET AL.chronic respiratory acidosis only marginally affects the
calcium content of bone (6). On the other hand, hypercap-
nia is considered a marker of severity of COPD (33). Thus,
hypercapnic patients are expected to have a longer history
of COPD and of exposure to risk factors for osteoporosis
clustering in COPD. The theoretical opposite effects on
bone mass of PCO2 per se and as a marker of disease severity
likely result in lack of a prevalent effect.
The direct relationship between nutritional indices and
BMD confirms findings pertaining to normal populations
as well as to a Japanese and an American COPD
population (4,5,34,35). It is worth observing that BMI is
an index of the average nutritional status, MAMC reflects
lean body mass, MAC partially depends upon the width of
the humeral bone and TSF is an index of fat mass. Thesefour indices exploring different aspects of anthropometric
and nutritional status were correlated with BMD. Indeed,
fat tissue might benefit BMD of post-menopausal women
by a direct mechanical effect and by converting androste-
nedione to estrone, whereas lean body mass partially
depends upon testosterone levels which also increase bone
mass in men (36,37). On the contrary, health outcomes
could not distinguish patients with and without osteoporo-
sis as if loss of BMD did not in parallel decline in disease-
related health status (38). It should be considered that
health outcomes can be considered the end result of a
complex interaction among clinical, respiratory function,
behavioural, psychological and social variables in condi-
tioning quality of life. Accordingly, health outcomes do not
qualify as direct indicators of disease severity, but as
OSTEOPOROSIS AND COPD 1083‘summary indicators’ of the health status. This limits our
understanding of their meaning and, thus, of their relation-
ship to BMD.
The lack of independent correlates of osteoporosis
besides low BMI might reflect some limitation of the
retrospective assessment of health-related behaviours and/
or a prevailing pathogenetic role of presently unexplored
determinants of osteoporosis such as inadequate peak bone
mass and genetic factors (39). A recent report on the risk of
osteoporosis in asthmatic women shows that the duration
of use of inhaled steroids, expressed in years, is inversely
correlated with spinal BMD (40). We could not test such a
relationship because information on pharmacological
treatment was limited to the year prior to the study.
Furthermore, the level of physical independence, quantified
by the Barthel index, does not necessarily reflect the daily
physical activity, a well-recognized protective factor against
loss of BMD. The recently reported lack of differences in
BMD between COPD patients who were chronically
administered oral or topic steroids contributes to explain
the present findings (5): the very low prevalence (15?4%) of
patients free from steroid therapy through any route limits
the possibility of disclosing any relationship between
steroid use and BMD. These limitations might have
concealed other potential correlates of BMD, but cannot
throw any doubt upon the observed correlation with
nutritional status.
In conclusion, poor nutritional status is a strong
correlate of low BMD in COPD patients. Further research
is needed to verify whether malnutrition qualifies as a
generic indicator of COPD severity and/or marks a
population suffering from an hypercatabolic status also
involving the bone. Indeed, a well-defined pattern of
cytokine production inducing hypercatabolism has
been found to characterize a consistent proportion of
COPD patients (41). Present results also allow us to
exclude that slight to moderate hypercapnia has any
effect on BMD. Attempts should be made to better
define both determinants and prognostic relevance of
mineral bone loss in COPD. Indeed, subjects with
lumbar or femoral fractures are frequently found
to suffer from COPD (42,43). However, this might reflect
the higher prevalence of COPD in the elderly and the
relatively old age of COPD patients rather than a causal
link between COPD and fractures. The possibility that
osteoporosis affects respiratory function either by increas-
ing dorsal kyphosis or by limiting the inspiratory effort to
prevent costal and vertebral pain also deserves considera-
tion (44). Thus, the present study opens some perspective of
research in a field where it is quite dicult to disentangle
the complex interaction of several factors conditioning the
loss of BMD.
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